ABSTRACT
Introduction
Studies have proved that the influenza vaccine can effectively reduce influenza-related hospitalizations and mortality [1] [2] [3] ; therefore, many Western countries encourage the elderly and other vulnerable patient groups to receive influenza vaccinations [4] . In 1998, the Taiwan government implemented a policy allowing elderly people at high risk of contracting influenza to be vaccinated at no charge. In 2001, this vaccination policy was expanded to cover all elderly regardless of risk status. Later, because of the substantial economic loss that Taiwan incurred during the 2003 SARS epidemic, the influenza vaccination was made available to all people aged 55 years and older free of charge, making Taiwan's influenza vaccination program one of the most generous in the world [5] . As understood, however, the effectiveness of the influenza vaccine has been reported to depend on the similarity between the virus strains in the vaccine and those in circulation in the population, age, immunocompetence of a vaccine recipient, chronic conditions of a vaccine recipient, and the timing of the vaccination [6] . Thus, although the government was making public health vaccination more freely available, a fundamental policy question was raised about how effective the influenza vaccination was at preventing clinical cases of influenza.
The effectiveness of influenza vaccination in reducing influenza-related illnesses, hospitalization, and death is well established in persons aged 65 years or older [3, [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] , and it is suggested that all people of this age be immunized annually [3, 18, 19] . On the other hand, studies in the United States have shown the cost-effectiveness or cost-benefits of the influenza vaccine for people with different levels of health risk [3, 8, 10, 11, 20, 21] . Cost-benefit and cost-effectiveness studies from other countries, including Canada [22] , England and Wales, France, Germany [23] , The Netherlands [24] , New Zealand [25] , and some local areas in Taiwan [26] , also suggest that vaccinating the elderly is cost-effective and frequently cost saving, although a few have not [27, 28] .
Results from economic studies on influenza vaccination, however, often have certain limitations and at times have methodological problems. Indeed, the most preferable study design for this issue would be a randomized controlled trial. Nevertheless, because the incidence rate of influenza-related severe complications is low, clinical trials often need large sample size and thus are extremely expensive. On the other hand, there have also been ethical concerns in clinical trials with regard to offering or not offering vaccinations to vulnerable people [29] . These selection and exclusion criteria limit the generalization of clinical trial results to the general population. As a result, nonexperimental studies were more often seen than clinical trials.
Extreme caution should be used when interpreting the conclusions of nonexperimental vaccination studies. Experimental and nonexperimental designs differ mainly in the absence of random allocation of intervention, which causes the problem of self-selection and biased estimates. In nonexperimental influenza vaccine studies, vaccine groups typically consist of patients with more severe diseases or people perceived to be at higher risk than nonvaccinated groups (self-selection) [30] . Those contraindicated for intervention are often allocated to the control group only. The effects of such perceptions of risk or health needs on defensive behavior have been identified in studies on HIV infection [31] and measles infections [32] . The selection of intervention (vaccination) is confounded by clinical and nonclinical patient factors, resulting in invalid inferences about the effectiveness of influenza vaccination. Having a poorer health status has been positively associated with a greater likelihood of being vaccinated [30, 33] , which might indicate self-selection by the patient or possibly an assessment of the patient's health by the physician [34] . Thus, ignoring selection bias would possibly lead to the underestimation of the effect of influenza vaccine for those vaccinated individuals, because they are often in poorer health and are more likely to get sick than those unvaccinated.
In Taiwan, the effectiveness of influenza vaccination in the elderly has been analyzed mainly by three studies [26, 35, 36] , all focusing on mortality and hospitalization. One reported national statistics on health outcomes [36] ; the other two analyzed secondary data of hospitalization and mortality, collected for a specific county or city [26, 35] . These studies were subject to the limitations of generalization to nationwide elderly and selection bias of being vaccinated [35] , which might bias the evaluation of the effectiveness of the influenza vaccination. Given these findings, evidence on minor cases is so far not available whether the influenza vaccine could not only reduce death and hospitalization for severe cases but also reduce general influenza and upper respiratory infections (URI) in Taiwan, suggesting that it can limit the spread of an epidemic.
In the present observational study, we examined whether being vaccinated reduced the risk of URI, measured by the occurrence of outpatient visits, among the elderly in Taiwan. Our data were drawn from a national health interview survey carried out between August 2001 and January 2002 and National Health Insurance (NHI) outpatient records for elderly aged 65 years or older for the year 2002. We used a propensity scoring method to reassign individuals to different groups (with a similar probability of receiving an influenza vaccine) and included the groups into survival analysis to compare the risk of URI outpatient visits in elderly people vaccinated with the influenza vaccine just before the beginning of a year in which an influenza epidemic occurred and in those who were not vaccinated at that time.
Methods
To adjust for the potential bias caused by selfselection, we used a propensity scoring method [37] based on logistic regression of spatial random effect to categorize patients into propensity groups. Propensity score group 1 (PSG 1) were those with a predicted probability of being vaccinated lower than 0.5, and PSG 2 group were those with a predicted probability of being vaccinated of 0.5 or higher. With the two PSG groups, we used survival analysis to examine the effect of vaccination on 1) the occurrence of outpatient visits for URI, and 2) the occurrence of either hospitalization for lung-related diseases or outpatient visits for URI.
Data Sources
Data were drawn from two sources: the 2001 National Health Interview Survey (NHIS) and the National Health Insurance outpatient records of interviewees who consented to the linking of the information from the two sources. The data from the 2001 NHIS were collected between August 2001 and January 2002. The survey had two parts: a representative sample of Taiwan's population of 23 million people and an oversampling of residents in the mountain regions and Taiwan's various offshore islands. The survey used a stratified multistage sampling design with the probability of selection proportional to the population size. The primary sample units consisted of 368 townships throughout Taiwan and outlying islands, 12 districts within the Municipality of Taipei, and 11 districts within the Municipality of Kaohsiung. Each primary sample unit was segmented according to level of urbanization, defined by socioeconomic and demographic characteristics. The segment clusters were then chosen by area to serve as the basic sampling that the survey would target. All family members of each sampled household were included in our sample. A participant's survey data were linked with his or her NHI data by personal identification number only if he or she signed an informed consent form allowing the linking of the information from both sources.
We selected 23,473 surveyed individuals (5798 households), representative of Taiwan's general population. From those 23,473 individuals, we selected 2110 elderly persons aged 65 years or older. We excluded 381 interviewees who did not sign the informed consent allowing their survey data and NHI data to be linked, leaving us with a total of 1729 elderly persons. Table 1 compares the differences between those who did not sign the informed consent with those who did. Those who did not sign the informed consent were more likely to be female (P < 0.05), illiterate (P < 0.0038), uncoupled (P < 0.005), high-risk, or have fewer family members with URI during the study period.
Influenza Season
According to the US Centers for Disease Control and Prevention (CDC), the worldwide influenza season was from October 2001 to May 2002 [38] . According to the criteria used in the literature [35] , the influenza season in Taiwan in our study was defined based on active influenza-surveillance data from the CDC in Taiwan [39, 40] 
Variable Definition
To evaluate the effect of the influenza vaccination on flu-related clinical events, we measured the clinical events in two ways: 1) the first time the patient went to the outpatient clinic for URI, and 2) the first time the patient went to an outpatient clinic or was hospitalized for a lung-related disease. and their vaccination date. Once vaccinated, they were reassigned to a new-case group. 2. Hospitalization for lung-related diseases or outpatient visits for URI. During the same observation period, we selected inpatient data with diagnoses of influenza, pneumonia, and lung-related disease, as defined previously [41] , as flu-related clinical cases. To combine these data with the outpatient visits for URI, we selected the earliest clinical event occurring during the observation period. That is, if the patient had been hospitalized before any outpatient visit, the time of hospitalization was selected as time that a flu-related clinical event occurred; otherwise, the outpatient visit date was identified as the first flu-related clinical event.
Vaccination variable and propensity score group (PSG). The vaccination date was defined as the date recorded on the NHI outpatient claim. If patients received a vaccination during the period that the vaccine was being offered free of charge, they were assigned the dummy variable VCC of 1; if they did not receive this vaccination during this period, they were assigned the dummy variable 0. In assigning the PSG, we used logistic regression to predict the probability of being vaccinated (see Statistical Analysis). Patients who had a predicted probability of being vaccinated lower than 0.5 were assigned to PSG 1; those with a probability of 0.5 or higher, to PSG 2.
In the logistic regression for propensity score, we used a continuous variable of OPD_URI6, the number of outpatient visits for URI during the 6 months before the vaccination date. Patients who were not vaccinated were assigned a number of OPD_URI6, based on the accumulated number of outpatient visits for URI before the first day free vaccination was offered. In our evaluation of the effect of vaccination on outpatient visits for URI, we included a variable indicating risk of exposure to URI. To do this, we used NHI claim data for each of sample patient's household members to count the number of members who had visited an outpatient clinic for URI during the study period. This variable of EXPOSURE to URI was measured as the number of family members with URI during the study period. The other independent variables included age in years (AGE); a dummy variable for SEX (1 for male and 0 for female); five educational levels (EDUCA-TION with reference group being illiterate); a dummy variable for being coupled (MARRIED = 1 for being coupled and 0 uncoupled); a dummy variable for employment status (EMPLOYMENT) (1 being employed and 0 unemployed); a dummy variable for whether one belonged to a high-risk group (HIGH-RISK) (1 as self-reported existing heart disease, lung disease, diabetes, stroke, renal disease, catastrophic illness informed by the health professions; 0 for no indication of these risks); monthly household income (NT$); and whether the household was receiving government welfare subsidy.
Statistical Analysis
Propensity score method. We used the propensity score model as an analytical adjustment strategy to measure the effect of influenza vaccination on reducing outpatient visits for URI. The propensity score method attempts to replicate an experimental design by comparing the outpatient visits for otherwise very similar individuals. Individuals were aligned based on their predicted probability of being vaccinated, and vaccinated individuals were matched with nonusers with a similar probability of being vaccinated. This matching process balanced the two groups on the observed factors that affect being vaccinated.
Previous studies have associated being vaccinated with insurance reimbursement program [42] , time cost [30] , and out-of-pocket costs [43, 44] . Concerns about possible side effects and disbelief in the efficacy of vaccine have been among the main reasons for individuals not to take advantage of influenza vaccinations [45, 46] . Other reasons for not being vaccinated are lack of physician recommendation [34] and disappointing overall immunization rates [3, 42, 46] . In addition to these factors, defensive behavior-perceptions of risk or health needs has been found to be significantly associated with the decision to receive a vaccination [30] [31] [32] .
In this study, for each individual j in the region i, we used a logistic regression with spatial random-effect to estimate the probability of being vaccinated as a function of age, sex, education, being married, being in a high-risk group, employment status, income level, receiving subsidy, and outpatient visit 6 months before receiving a vaccination (OPD_URI6).
where Pr(VCC ij = 1) is the probability of the jth individual's being vaccinated in the region i, and b i is the spatial random effects for adjusting the variation in the space. Those random effects are often assumed to follow a normal distribution with zero mean and covariance matrix D.
From this logistic regression, we predicted the probability of receiving a vaccination based on each individual's observed variables. This prediction is called the propensity score, e(x), estimated by e(x) = Pr(VCC ij = 1). Patients who had a predicted probability of receiving a vaccination lower than 0.5 were assigned to PSG 1; those with a probability of 0.5 or higher, to PSG 2. This PSG was included in the survival analysis.
Survival analysis of URI.
A Cox proportional hazards model was used to evaluate the association between receiving a vaccination and occurrence of URI. In the Cox proportional hazards model, the individual's hazard function is proportional to those of the others. For the purposes of this study, we used three models of survival analysis: Model 1. The Cox proportional hazards model was fitted for total study sample:
The hazard function is where t denotes survival time, h 0 (t) denotes the baseline hazard function, (x 1 ,x 2 , . . . ,x p ) denotes the covariates, and (α 1 ,α 2 , . . . ,α p ) denotes the coefficients of covariates. The common assumption in models 1 and 2 was that the underlying hazard function h 0 (t) was the same in the vaccinated and unvaccinated group in time t. This assumption is relaxed in the stratified Cox proportional hazards model, in which the underlying hazard function is different for the two groups. The regression coefficients, however, are the same for all groups. Given a propensity score PSG, the hazard function is for i = 1,2 denotes the vaccinated and unvaccinated group, respectively. Table 2 compares data on those who were vaccinated (n = 867) with those who were not (n = 862). Without any adjustment, the unvaccinated group had a higher probability of having URI outpatient visits (32.25% vs. 23.76%, P < 0.0001) and hospitalization for lung-related diseases (6.42% vs. 3.11%, P < 0.0036) than the vaccinated group. Among those who had URI outpatient visits, the unvaccinated group had fewer number visits (2.65 vs. 2.81, P < 0.05) than the vaccinated group, but their first-time URI outpatient visit occurred nearly 50 days earlier than the vaccinated group (150 days vs. 201 days, P < 0.0001). The results of random-effect logistic regression on receiving an influenza vaccine show that visiting an outpatient clinic for URI before the study period is positively associated with the likelihood of receiving an influenza vaccination (odds ratio (OR) 1.07; 95% confidence interval (CI) 1.04-1.10) ( Table 3) . Compared with the illiterate patients, patients who were literate or had elementary-level education (OR 1.19; 95% CI 1.04-1.37) and junior high-school graduatelevel education (OR 1.17; 95% CI 1.03-1.32) were more likely to receive a flu vaccination. Uncoupled elderly patients were less likely to receive an influenza vaccination than coupled patients (OR 0.82; 95% CI 0.72-0.92). Receiving welfare subsidies from the government was positively associated with receiving an influenza vaccination (OR 1.26; 95% CI 1.01-1.58). Adding spatial random effect into logistic regression a increased the pseudo R 2 from 0.0224 to 0.0122. We classified the patients with a predicted probability of receiving an influenza vaccination lower than 0.5 into PSG 1 and those with probability of 0.5 or higher into PSG 2. Sixty percent of the elderly were in PSG 1, with a vaccination rate of 42.9%; 40% of the elderly were in PSG 2, with a vaccination rate of 62.9%. Table 4 shows the survival analysis results on URI outpatient visits of model 1 (total sample) and model 2 (stratified by PSG group). The same analysis was repeated once, this time including inpatients with hospitalization event in outcome measurement. The assumption of the Cox proportional hazards model, which was one's hazard was proportional to another, was tested, and found to be a reasonable assumption (all P-values greater than 0.05). On the other hand, analysis of residuals showed that the residuals were distributed around 0, between −3 and 3 with no particular pattern, which indicated the model. Model 1, the pooled model on total elderly, showed that receiving a vaccination significantly reduced the risk of URI outpatient visits (adjusted hazard ratio (HR) 0.93; 95% CI 0.87-0.99). The elderly in the high-risk group were indeed at a significantly higher risk of URI (HR 1.13; 95% CI 1.07-1.19) than the elderly who were not. The number of family members with NHI outpatient claims for visits for URI was not associated with risk of URI (HR 1.02; 95% CI 0.97-1.08).
Results
In model 2, the survival analysis of the Cox proportional hazards model was carried out, stratified by propensity groups. In PSG 1, receiving a vaccination did not reduce the risk of URI (HR 0.91; 95% CI 0.81-1.01). The patients in the high-risk group had a significantly higher risk of URI (HR 1.18; 95% CI 1.08-1.28) than elderly patients who were not. Having more family members with URI during the study period did not increase the risk of URI (HR 1.05; 95% CI 0.96-1.14). In PSG 2 (0.5 or higher), receiving a vaccination did significantly reduce the risk of URI outpatient visits (HR 0.89; 95% CI 0.81-0.97). In that same group, uncoupled elderly patients had a higher risk of URI than coupled patients (HR 1.10; 95% CI 1.00-1.21). As was found for PSG 1, the number of family members with URI in PSG 2 with URI did not influence the risk of URI (HR 1.00; 95% CI 0.92-1.07).
The results of model 3, the stratified Cox-proportion hazards model, are not shown in Table 4 , but were plotted in two graphs in Figure 1 , the first graph for propensity scores of less than 0.5 (PSG 1) and the second for propensity scores PSG 2. The survival curves with 95% CI lines in each graph show the first outpatient visits for URI in 365 days from the beginning of the influenza season. The vaccinated group was represented by a solid line and the unvaccinated group by a dash line. Although results in Table 4 show that vaccine did not have a significant effect on reducing risk of URI outpatient visits in PSG 1, the whole year, results drawn from the stratified Cox proportional hazards model showed that, for both PSG, receiving a vaccination significantly reduced the occurrence of URI outpatient visits in the first 3 months of the influenza epidemic. In addition, the effect of the vaccine was stronger in PSG 2.
Conclusion and Discussion
Influenza epidemics of varying severity occur almost yearly and have a significant impact on the health of people and medical costs. Although Taiwan's government is making public health vaccination more freely available, interest groups in the field are raising fundamental policy questions about how effective influenza vaccination is at preventing clinical cases of influenza. Our observational study attempts to answer this question. To make up for the limitation found in general nonexperimental studies, we linked unique data sets: 1) NHIS to obtain detailed demographic data, and 2) NHI claim data to identify the status of vaccination and to retrieve records of outpatient visits made by the subjects and their family members.
We used survival analysis to analyze the first outpatient visits for URI with analytical adjustment of the propensity score method to adjust potential selection bias, which was often ignored in nonexperimental studies. We found the elderly in Taiwan to have a vaccination rate of 50% and the overall probability that an elderly patient would visit an outpatient clinic for URI to be 27.99%. Using data on occurrences of outpatient visits for URI, our survival analysis showed that being vaccinated significantly reduced the risk of URI by nearly 7% in the elderly in Taiwan. The effect was more obvious (11%) among individuals identified as being more likely to receive a vaccination. The effect of the vaccine was even more significant during the first 3 months of the influenza season than in the rest of the study period. The results did not vary much when we incorporated the events of hospitalization into our analysis.
Our study design on survival analysis on total sample and on two PSG provides some valuable and detailed information. First, the vaccine effect on PSG 1 (lower probability of being vaccinated) group was not significant. This highlights the importance of the propensity score method. Without stratifying the analysis into two PSG, it would be very easy to believe that vaccination had the same effect on all individuals. Second, adding Figure 1 drawn from separate survival analyses showed that the effect of the vaccine was more significant, even in PSG 1, during the first 3 months rather than the whole year. In addition, the graph showed that the vaccine effect on PSG 2 was larger than its effect on PSG 1. Nonetheless, we admit that further analysis should examine whether influenza vaccine not only postpones the occurrence of URI (limiting the speed of epidemic) but also reduces the frequency of URI visits (the scope of the epidemic). Before examining that, we cannot conclude that Taiwan's the vaccination program effectively reduced overall outpatient visits for URI in the elderly.
Several factors should be taken into account when drawing inferences from our study. First, nearly 18% of the elderly people who were interviewed did not sign the informed consent allowing us to link survey data with NHI data. Those who declined to give consent were more likely to be female, illiterate, and uncoupled. Being uncoupled was significantly associated with a higher probability of not being vaccinated. Being uncoupled was also positively associated with a higher risk of URI. Thus, we suspect that by excluding these individuals our results may have underestimated the influenza vaccine effect.
Second, strong presumptions were made in measuring the occurrence of URI. In our study, we used the secondary data of outpatient visits for URI as the proxy of occurrence of URI, which was based on strong presumptions: 1) people usually go to outpatient care when they have a cold or flu; 2) people with flu and cold have the same utilization pattern of health care; and 3) the diagnosis code at outpatient visits correctly reflects the true clinical condition. There exists no published evidence to verify the validity of the claim data and its relationship with clinical condition. The answer to the survey question of whether a patient would choose to visit a physician of Western medicine when he or she feels ill on the NHIS provided us with some helpful information: 76.56% of the elderly reported they would choose to visit the physician. An unpublished analysis of the NHIS on the consistency between the self-report outpatient visits and NHI outpatient claim data showed that the kappa value was 0.64 and the agreement level between the claim data and whether the interviewee ever visited the physician as well as the number of visits in the past 1 month was 67.5%. Nevertheless, three strong presumptions could have possibly biased our measure on clinical condition of URI.
Third, although we used propensity score as analytical adjustment for potential selection bias of being vaccinated on outpatient visit, the difference of hazards ratio was small. The reader should bear in mind that propensity score is a method of reconstructing, after the fact, a situation similar to random assignment, with respect to observed prognostic variables. Based on the design, the comparisons of vaccinated and unvaccinated groups are being made within groups of similar individuals, who had the same chance of receiving treatment. The adjustment was based, however, on overt biases; that is to say, the propensity score method does little or nothing to address hidden biases due to unobserved or unre-corded differences between treated and control individuals [47] .
Fourth, although our study had the advantage of having access to individual characteristics drawn from the NHIS and detailed claim data, allowing us to identify a number of "overt" variables such as health status and socioeconomic status and relate them to both vaccination and outpatient visits, our study was not able to control hidden biases possibly caused by other unobserved variables such as traffic commute or accessibility of health care. The goodness-of-fit test of the model (Hosmer-Lemeshow goodness-of-fit test) was 6.03 with a P-value of 0.64, suggesting that the estimate on vaccine effect with propensity score adjustment would still be biased if these unobserved variables had strong relationships with both vaccination and outpatient visits.
In conclusion, considering the effectiveness of the vaccination on controlling the spread of the epidemic, it is unfortunate that only 50.1% of the elderly aged 65 years or older received influenza vaccinations in 2002. This was a especially low figure, considering that the vaccination was being provided free of charge. In light of our findings, we believe more could be done to increase the vaccination rate in people aged 76 years or older, illiterate elderly people, and uncoupled elderly patients, as there may be social barriers to access to the public health system. Furthermore, our finding that people with preepidemic outpatient visits were more likely to be vaccinated possibly indicates that either the physician recommended vaccinations [34] to frequent care-users or that these patients were more likely to take defensive measures (perceptions of risk or health needs [30] [31] [32] ). Based on these reports, we should try to provide more education or information on influenza vaccination, particularly its effect on preventing outbreaks of epidemic, directly to those who do not make much use of outpatient care and those who do not think they need the vaccine.
